Antiretroviral therapy non-adherence among children living with HIV in Dire Dawa, Eastern Ethiopia : a case-control study
(2022) In BMC Pediatrics 22(1).- Abstract
Background: In 2018, nearly 90% of the global
children living with human immunodeficiency virus (HIV) were in
sub-Saharan Africa (SSA). Compared to the adult population,
antiretroviral therapy (ART) coverage among children was limited.
However, adherence remained a problem among children though they had
limited access to ART. This study was conducted to identify the risk
factors of non-adherence to ART among children aged 6 to 17 years.
Methods:: This case-control study was conducted in 2020 using data
obtained from clinical record reviews and self-reported data from 272
caregivers of HIV-infected children aged 6–17 years. Cases and controls
represented children with poor versus children... (More)Background: In 2018, nearly 90% of the global
(Less)
children living with human immunodeficiency virus (HIV) were in
sub-Saharan Africa (SSA). Compared to the adult population,
antiretroviral therapy (ART) coverage among children was limited.
However, adherence remained a problem among children though they had
limited access to ART. This study was conducted to identify the risk
factors of non-adherence to ART among children aged 6 to 17 years.
Methods:: This case-control study was conducted in 2020 using data
obtained from clinical record reviews and self-reported data from 272
caregivers of HIV-infected children aged 6–17 years. Cases and controls
represented children with poor versus children with good adherence to
ART, respectively. Good adherence was defined based on a past 30-day
physician adherence evaluation of taking ≥ 95% of the prescribed doses.
Binary logistic regression was used to identify factors associated with
non-adherence to ART. All statistical tests are defined as statistically
significant at P-values < 0.05. Results:: Of the 272 children, for
whom data were obtained, 78 were cases and 194 were controls; females
accounted for 56.3%, 32% attended secondary school, and for 83.1%, the
reporting caregivers were biological parents. Non-adherent children had
higher odds of association with the following risk factors: a caregiver
who is a current substance user (aOR = 2.87, 95% CI: 1.44, 5.71), using
AZT-and ABC-based regimen compared to the TDF-regimen (AZT-based, aOR =
4.12, 95% CI: 1.43, 11.86; ABC-based, aOR = 5.58, 95% CI: 1.70, 18.30),
and had an increase in viral load from baseline compared to those
remained undetectable (remained at or decreased to < 1000, aOR =
4.87, 95% CI: 1.65, 14.33; remained at ≥ 1000, aOR = 9.30, 95% CI: 3.69,
23.46). In contrast, non-adherent children had 66% lower odds of being
at early adolescent age compared to 6–9 years old (10–14 years, aOR =
0.34, 95% CI: 0.12, 0.99) and had 70% lower odds of being aware of their
HIV status (aOR = 0.30, 95% CI: 0.13, 0.73). Conclusion:: Technical
support to caregivers to build disclosure self-efficacy, identifying the
appropriate regimen for children, counseling on viral load suppression
on subsequent visits, and helping caregivers avoid or reduce substance
use may help improve the problem of children’s non-adherence to ART.
- author
- Mengesha, Melkamu Merid
LU
; Embibel, Mulugeta
; Gobena, Tesfaye
; Tunje, Abayneh
LU
; Jerene, Degu
LU
and Hallström, Inger Kristensson
LU
- organization
- publishing date
- 2022
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- and viral load, Children, HIV status disclosure, Non-adherence to ART
- in
- BMC Pediatrics
- volume
- 22
- issue
- 1
- article number
- 653
- publisher
- BioMed Central (BMC)
- external identifiers
-
- scopus:85141610922
- pmid:36357856
- ISSN
- 1471-2431
- DOI
- 10.1186/s12887-022-03697-1
- project
- eHealth as an aid for facilitating and supporting self-management in families with long-term childhood illness – development, evaluation and implementation in clinical practice
- Improving adherence to antiretroviral therapy among adolescents living with HIV in Ethiopia
- language
- English
- LU publication?
- yes
- id
- 759ba76e-2678-425c-b8dd-d723eba05596
- date added to LUP
- 2022-12-05 12:07:13
- date last changed
- 2025-11-01 20:27:11
@article{759ba76e-2678-425c-b8dd-d723eba05596,
abstract = {{<p>Background: In 2018, nearly 90% of the global <br>
children living with human immunodeficiency virus (HIV) were in <br>
sub-Saharan Africa (SSA). Compared to the adult population, <br>
antiretroviral therapy (ART) coverage among children was limited. <br>
However, adherence remained a problem among children though they had <br>
limited access to ART. This study was conducted to identify the risk <br>
factors of non-adherence to ART among children aged 6 to 17 years. <br>
Methods:: This case-control study was conducted in 2020 using data <br>
obtained from clinical record reviews and self-reported data from 272 <br>
caregivers of HIV-infected children aged 6–17 years. Cases and controls <br>
represented children with poor versus children with good adherence to <br>
ART, respectively. Good adherence was defined based on a past 30-day <br>
physician adherence evaluation of taking ≥ 95% of the prescribed doses. <br>
Binary logistic regression was used to identify factors associated with <br>
non-adherence to ART. All statistical tests are defined as statistically<br>
significant at P-values < 0.05. Results:: Of the 272 children, for <br>
whom data were obtained, 78 were cases and 194 were controls; females <br>
accounted for 56.3%, 32% attended secondary school, and for 83.1%, the <br>
reporting caregivers were biological parents. Non-adherent children had <br>
higher odds of association with the following risk factors: a caregiver <br>
who is a current substance user (aOR = 2.87, 95% CI: 1.44, 5.71), using <br>
AZT-and ABC-based regimen compared to the TDF-regimen (AZT-based, aOR = <br>
4.12, 95% CI: 1.43, 11.86; ABC-based, aOR = 5.58, 95% CI: 1.70, 18.30), <br>
and had an increase in viral load from baseline compared to those <br>
remained undetectable (remained at or decreased to < 1000, aOR = <br>
4.87, 95% CI: 1.65, 14.33; remained at ≥ 1000, aOR = 9.30, 95% CI: 3.69,<br>
23.46). In contrast, non-adherent children had 66% lower odds of being <br>
at early adolescent age compared to 6–9 years old (10–14 years, aOR = <br>
0.34, 95% CI: 0.12, 0.99) and had 70% lower odds of being aware of their<br>
HIV status (aOR = 0.30, 95% CI: 0.13, 0.73). Conclusion:: Technical <br>
support to caregivers to build disclosure self-efficacy, identifying the<br>
appropriate regimen for children, counseling on viral load suppression <br>
on subsequent visits, and helping caregivers avoid or reduce substance <br>
use may help improve the problem of children’s non-adherence to ART.</p>}},
author = {{Mengesha, Melkamu Merid and Embibel, Mulugeta and Gobena, Tesfaye and Tunje, Abayneh and Jerene, Degu and Hallström, Inger Kristensson}},
issn = {{1471-2431}},
keywords = {{and viral load; Children; HIV status disclosure; Non-adherence to ART}},
language = {{eng}},
number = {{1}},
publisher = {{BioMed Central (BMC)}},
series = {{BMC Pediatrics}},
title = {{Antiretroviral therapy non-adherence among children living with HIV in Dire Dawa, Eastern Ethiopia : a case-control study}},
url = {{http://dx.doi.org/10.1186/s12887-022-03697-1}},
doi = {{10.1186/s12887-022-03697-1}},
volume = {{22}},
year = {{2022}},
}